COMPANY 

INSIGHT

Sponsored by

High precision, low friction and low energy consumption

With headquarters located in Biel/Bienne Switzerland, MPS Micro Precision Systems AG develops and manufactures highly complex and very precise mechanical and electro-mechanical microsystems used in the Medtech, Automation and Watch industries.

In a spacious and modern architecture the 400 employees of MPS transform customer requirements and specifications into robust and reliable products and systems.

MPS supplies to a Blue Chip Medtech company in the US the dosing system for a programmable implantable infusion pump. The pump’s main requirement is to deliver a specific amount of medication using the energy stored in an embedded battery. To guarantee this requirement over the entire lifetime of the product (7 years), MPS has optimised a very precise implantable microsystem which performs the function with nearly no friction and therefore minimal energy consumption.

MPS Microsystems produces a system for a programmable implantable infusion pump (AIMD Class 3) that consumes low level of energy, that is biocompatible and also corrosion-resistant.
In close collaboration, MPS Microsystems produces a miniature and extremely accurate hexapod robot. This tool assists surgeons and offers them accurate positioning and movement during spine operations

Spine surgery is a very delicate operation, with success depending on the individual performance of the surgeon. MPS manufactures a small and very precisely adjustable spine surgery assist robot (positioning precision = 1µm), which makes the accuracy of the surgical procedure less dependent on the surgeon’s daily performance.

Biocompatible actuators

MPS’ biocompatible actuator technology consists of an encapsulated motor, electronics and power element, as well as a gearbox and leadscrew made of biocompatible materials. The actuators and electronics are designed for long term implantation and for wireless data and energy transfer. This technology has a wide range of applications in the orthopaedic, spine, CMF, urology and other markets.

Micro Robotics

Integrating as much functionality as possible into the smallest available space is a key competence of MPS and a requirement of the market for active implants. MPS engineers are combining their know-how in micro bearing technologies, the know-how of their parent company Faulhaber in micro motors and gear boxes and the competences of their electronic partner in order to develop and manufacture implantable, intelligent microsystems featuring low energy consumption.

Very high precision component manufacturing and system assembly in clean environment

Very precise components are at the heart of MPS’ microsystems. These components are manufactured at MPS own workshops in Biel/Bienne: Swiss turning, flat, round and centerless grinding as well as polishing yield components with tolerances lower than 1µm and to a surface roughness of less than 0.1 Ra. MPS is also well equipped for heat treatment and component cleaning.

Very impressive are MPS’s microsystems assembly capabilities: in order to reach the required repeatable precision and the lowest possible friction by keeping system stiffness, MPS has developed its own assembly processes and capabilities. Using MPS made assembly benches and jigs, the operators pair components to a precision of less than 0.2 µm in series production. Depending on the requirements, system assembly is taking place either in a dust free room or in a clean room ISO class 7.

Technical files

MPS project / product documentation conform to CE standards, 510k and PMA requirements. MPS customers may use this documentation to complete their submission dossier.

Orthopaedic instruments

Since December 2012 MPS has a new subsidiary named “MPS Precimed”. It is located in Bienne in the same facilities than MPS Micro Precision Systmes AG. With its 40 employees, MPS Precimed develops and manufactures innovative orthopaedics instruments for the main Blue Chip orthopaedic companies. Reamers, impactors and drills are part of MPS Precimed’s product portfolio.

Go to article: Home | For Sale: Med Tech MalwareGo to article: In This Issue Go to article: Formacoat Company InsightGo to article: FormacoatGo to article: Contents Go to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: NewsGo to article: Cap Biomaterials Company Insight Go to article: Cap BiomaterialsGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: The Medical Industry Briefing Go to article: Telemed Company InsightGo to article: TelemedGo to article: Under the skin: the medical device industry and the dark webGo to article: Braxton Manufacturing Go to article: ARPA Company InsightGo to article: ARPAGo to article: AI and open sourcing: a new frontier for prosthetic leg designGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company InsightGo to article: The age of the autonomous pharmacy Go to article: Sandvik Company InsightGo to article: Sandvik Go to article: Q&A: LifeBank on the challenge of getting blood from A to B in Nigeria Go to article: Mecmesin Company InsightGo to article: MecmesinGo to article: 5G meets medicine: separating fact from fictionGo to article: Maraca InternationalGo to article: Adhesives ResearchGo to article: Meril Life Sciences: leading a growing Indian medtech sectorGo to article: PI CeramicGo to article: Erdmann Design Go to article: Making electronic health records workGo to article: Thermal Press InternationalGo to article: Euroquartz Company InsightGo to article: EuroquartzGo to article: Snooze, you lose: the devices helping to understand the science of sleepGo to article: OptelGo to article: US makes strides in below-the-knee use of drug-coated balloonsGo to article: 3BYGo to article: Continuous glucose monitoring is quickly becoming standard-of-care for diabetes Go to article: Bright PlasticsGo to article: Bariatric surgery is driving factor for medical tourismGo to article: Art of TechnologyGo to article: Opportunities and challenges in China’s wound care marketGo to article: Tech NHGo to article: Bayer AG acquires BlueRock TherapeuticsGo to article: EventsGo to article: Next Issue